What is Castle Biosciences's accounts payable?

Castle Biosciences (CSTL) reported accounts payable of $15.04M in Q1 2026.

How has Castle Biosciences's accounts payable changed year-over-year?

Castle Biosciences's accounts payable increased by 76.9% year-over-year, from $8.5M to $15.04M.

What is the long-term trend for Castle Biosciences's accounts payable?

Over 5 years (2020 to 2025), Castle Biosciences's accounts payable has grown at a 54.9% compound annual growth rate (CAGR), from $2.1M to $18.71M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Castle Biosciences CSTL Accounts Payable

Accounts Payable at other companies

Labcorp HoldingsLH

$695.7M-3.1%

VeracyteVCYT

$6.91M-56.0%

Personalis, Inc.PSNL

$12.68M+60.2%

NeoGenomicsNEO

$25.9M+59.8%

Fulgent Genetics, Inc.FLGT

$21.13M+15.8%

Cogent Biosciences, Inc.COGT

$13.74M-2.9%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's accounts payable?: Castle Biosciences (CSTL) reported accounts payable of $15.04M in Q1 2026.
How has Castle Biosciences's accounts payable changed year-over-year?: Castle Biosciences's accounts payable increased by 76.9% year-over-year, from $8.5M to $15.04M.
What is the long-term trend for Castle Biosciences's accounts payable?: Over 5 years (2020 to 2025), Castle Biosciences's accounts payable has grown at a 54.9% compound annual growth rate (CAGR), from $2.1M to $18.71M.
What does accounts payable mean?: Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.